European Organisation For Research And Treatment Of Cancer - Eortc
Clinical trials sponsored by European Organisation For Research And Treatment Of Cancer - Eortc, explained in plain language.
-
New hope for AML patients: drug combo aims to beat standard chemo
Disease control Not yet recruitingThis study compares a new three-drug combination (gilteritinib, azacitidine, and venetoclax) to standard chemotherapy for adults newly diagnosed with a specific genetic subtype of acute myeloid leukemia (FLT3-ITD). About 230 participants aged 18-75 who are healthy enough for inte…
Phase: PHASE2, PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New combo attack on lung cancer brain spread: radiation first, then drugs
Disease control Not yet recruitingThis study tests two treatment plans for people with lung cancer that has spread to the brain but isn't causing major symptoms. One group gets targeted radiation to all brain tumors first, then a drug combo (ivonescimab plus chemo). The other group gets the drug combo alone. The …
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 20, 2026 11:57 UTC